Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Lab data continues to play a critical role in the strategy, design, and execution of clinical trials. Patients’ diagnostic touchpoints at provider organizations and in community settings inherently provide the patient centricity that’s at the core of decentralized trials. Executive Director, Healthcare Analytics Solutions Quest Diagnostics Parag More has more than 20-year career in healthcare and life sciences with focus on improving patient outcomes using data and technology innovations. In his current role as Executive Director, Healthcare Analytics Solutions at Quest Diagnostics, he responsible for leading the Clinical Trials business through market initiatives, solutions & services development, and industry partnerships. Prior to joining Quest, Parag served as a VP, Research & Insights group at Syneos Health where helped pharma & biotech companies develop and commercialize drug therapies with innovative use of advanced analytics. Parag also has provider, payor and GPO (group purchasing organization) experience from his time at GSI Health, Highmark Health and Premier. He has a successful track-record in building and scaling clinical informatics driven entrepreneurial ventures helping solve
problems in the fields of population health & clinical research.
In this presentation we will discuss how collaborating with a lab data partner is essential to optimizing trials.
This webinar will also will explore the shifting dynamics of patient and provider engagement for decentralized trials and demonstrate the importance of partnering with providers that are able to deploy engagement strategies for recruitment of clinically relevant participants. We will also discuss how lab results and population insights help assess trial risks, analyze feasibility, and improve on the success metrics of decentralized trials.
Speakers:
Parag More
Parag earned an MBA in strategy, corporate finance and entrepreneurship from NYU's Stern School of Business, a master's degree in computer science from Arizona State University, and a bachelor's degree in computer science from the University of Mumbai, India.
Custom Content Writer
Informa Pharma Intelligence
